Colorectal Cancer

Healio Gastroenterology and Liver Disease presents a list of some of the top stories that included some of the top research and discussions pertaining to interventional endoscopy presented at the American College of Gastroenterology Annual Meeting

In West Philadelphia, born and raised, in the endo suite is where Will Smith spent most of his day in August as he underwent his first colonoscopy. Smith, who turned 50 last year, was getting screened for colorectal cancer for the first time, but, unlike most people, decided to share his experience by posting a vlog on his YouTube page.

SAN ANTONIO — Patients who adhered to a single-day, low-residue diet prior to colonoscopy had a better bowel preparation and reported better tolerance compared with a clear liquid diet, according to study results presented at the American College of Gastroenterology Annual Meeting.

Adding panitumumab to FOLFOXIRI chemotherapy improved rates of overall response and secondary resection of metastases among patients with RAS wild-type metastatic colorectal cancer, according to results of the randomized phase 2 VOLFI trial published in Journal of Clinical Oncology.

The ACP has issued a new evidence-based guidance statement on screening for colorectal cancer screening in asymptomatic adults with average risk.

SAN ANTONIO — In this exclusive video from the American College of Gastroenterology Annual Meeting, Aasma Shaukat, MD, MPH, FACG, professor of medicine at University of Minnesota and GI Section Chief at the Minneapolis VA Medical Center, discusses a major debate in colorectal cancer screening and surveillance.

In this guest commentary, Paul J. Limburg, MD, discusses the need for increased awareness of colorectal cancer incidence among the younger population and the newer methods available for screening within this newly at-risk group.

The FDA’s approval of Xarelto to prevent blood clots in acutely ill hospitalized patients was one of the top stories in hematology/oncology last week.

A global study that spanned nearly 30 years in 195 countries has revealed different shifts in the trend of incidence and death rates of several gastrointestinal cancers, as well as the global burden of inflammatory bowel disease, according to data presented at UEG Week.

An increase in overall cancer mortality risk was found in patients with severe psoriasis, and associations were identified within site-specific cancers such as colon and kidney among patients with all severities of psoriasis, according to a systematic review of 58 studies that was published in JAMA Dermatology.